Chantal L. Duurland, Thijs de Gunst, Harm C. den Boer, and their team explore a groundbreaking approach to cancer treatment using the INT-1B3 miR-193a-3p mimic. This innovative therapy enhances T cell immunity and induces immunogenic cell death, showing potential for long-term tumor resistance. The researchers discuss the implications of their findings on the tumor microenvironment and how this method could revolutionize anti-tumor strategies. Expect insights into the future of immunotherapy and its transformative potential in cancer care.